FI944714L - Beta-karboliinien uusi käyttö - Google Patents
Beta-karboliinien uusi käyttö Download PDFInfo
- Publication number
- FI944714L FI944714L FI944714A FI944714A FI944714L FI 944714 L FI944714 L FI 944714L FI 944714 A FI944714 A FI 944714A FI 944714 A FI944714 A FI 944714A FI 944714 L FI944714 L FI 944714L
- Authority
- FI
- Finland
- Prior art keywords
- carbolines
- beta
- new use
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4212529A DE4212529A1 (de) | 1992-04-10 | 1992-04-10 | Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten |
| PCT/EP1993/000858 WO1993020820A1 (de) | 1992-04-10 | 1993-04-06 | NEUE VERWENDUNG VON β-CARBOLINEN |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI944714A0 FI944714A0 (fi) | 1994-10-07 |
| FI944714A7 FI944714A7 (fi) | 1994-10-07 |
| FI944714L true FI944714L (fi) | 1994-10-07 |
Family
ID=6456829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI944714A FI944714L (fi) | 1992-04-10 | 1993-04-06 | Beta-karboliinien uusi käyttö |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0633779A1 (fi) |
| JP (1) | JPH07505404A (fi) |
| KR (1) | KR950700739A (fi) |
| CA (1) | CA2117755A1 (fi) |
| DE (1) | DE4212529A1 (fi) |
| FI (1) | FI944714L (fi) |
| HU (1) | HUT68212A (fi) |
| IL (1) | IL105349A0 (fi) |
| WO (1) | WO1993020820A1 (fi) |
| ZA (1) | ZA932553B (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330175A1 (de) * | 1993-08-31 | 1995-03-02 | Schering Ag | Alkoxy-substituierte beta-Carboline |
| DE4436190A1 (de) * | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenierte ß-Carbolin-Derivate, Verfahren zu ihrer Herstellung und Verwendung dieser Substanzen zur Hemmung der Atmungskette |
| RU2106864C1 (ru) * | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| CN1230889A (zh) | 1996-09-27 | 1999-10-06 | 吉尔福特药业有限公司 | NAALADase组合物和治疗谷氨酸异常及在动物中产生神经元活性的方法 |
| AU2006254897A1 (en) * | 2005-06-06 | 2006-12-14 | Fibrogen, Inc. | Improved treatment for anemia using a HIF-alpha stabilising agent |
| CN119431371A (zh) * | 2024-10-22 | 2025-02-14 | 沈阳药科大学 | 一种β-卡波林3,6,9-位修饰衍生物及其制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3540653A1 (de) * | 1985-11-13 | 1987-05-14 | Schering Ag | Neue 3-oxadiazol- und 3-carbonsaeure-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
| DE3545776A1 (de) * | 1985-12-20 | 1987-06-25 | Schering Ag | 5-aminoalkyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
-
1992
- 1992-04-10 DE DE4212529A patent/DE4212529A1/de not_active Withdrawn
-
1993
- 1993-04-06 WO PCT/EP1993/000858 patent/WO1993020820A1/de not_active Ceased
- 1993-04-06 JP JP5517954A patent/JPH07505404A/ja active Pending
- 1993-04-06 EP EP93908924A patent/EP0633779A1/de not_active Withdrawn
- 1993-04-06 FI FI944714A patent/FI944714L/fi not_active Application Discontinuation
- 1993-04-06 HU HU9402925A patent/HUT68212A/hu unknown
- 1993-04-06 CA CA002117755A patent/CA2117755A1/en not_active Abandoned
- 1993-04-08 ZA ZA932553A patent/ZA932553B/xx unknown
- 1993-04-09 IL IL105349A patent/IL105349A0/xx unknown
-
1994
- 1994-10-08 KR KR1019940703566A patent/KR950700739A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0633779A1 (de) | 1995-01-18 |
| WO1993020820A1 (de) | 1993-10-28 |
| HU9402925D0 (en) | 1995-01-30 |
| KR950700739A (ko) | 1995-02-20 |
| FI944714A0 (fi) | 1994-10-07 |
| DE4212529A1 (de) | 1993-10-14 |
| CA2117755A1 (en) | 1993-10-11 |
| FI944714A7 (fi) | 1994-10-07 |
| ZA932553B (en) | 1993-11-02 |
| HUT68212A (en) | 1995-06-28 |
| IL105349A0 (en) | 1993-08-18 |
| JPH07505404A (ja) | 1995-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI944885A7 (fi) | Tölkin perusosa | |
| NO934622D0 (no) | Imidazopyridiner | |
| FI945441A7 (fi) | Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmi stamiseksi | |
| NO932218D0 (no) | Imidazopyridiner | |
| NO307250B1 (no) | Brokran | |
| DE69325124D1 (de) | Sauerstoffmesssonde | |
| FI944714A7 (fi) | Beta-karboliinien uusi käyttö | |
| ITPD920145A0 (it) | Uso terapeutico della fosforil-serina-n-acil-sfingosina | |
| NO931302D0 (no) | Imidazopyridiner | |
| NO940190D0 (no) | Anvendelse av x-ketoglutarat | |
| FI930022A0 (fi) | Kemiskt foerfarande | |
| NO933804L (no) | Imidazopyridiner | |
| NO931399D0 (no) | Anvendelse av naturstein | |
| FI933203A0 (fi) | Kinolin- och naftyridinprolaekemedel | |
| DE69310526D1 (de) | Reinigungsverfahren | |
| NO944839D0 (no) | Anvendelse av vismut | |
| FI934864A0 (fi) | Bicykliska karbamater | |
| KR930026760U (ko) | Tvcr의 개선된 구성 | |
| SE9203080D0 (sv) | Lindragare foer bruk under is | |
| FI531U1 (fi) | Grund foer en pelare | |
| LV10073A (lv) | Skidinataju absolutizesanas panemiens | |
| KR940016979U (ko) | 시계바늘의 결합구조 | |
| DK80592D0 (da) | Fremgangsmaade | |
| DK86992D0 (da) | Fremgangsmaade | |
| DK103092D0 (da) | Fremgangsmaade |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |